BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 3138627)

  • 1. [Cost/benefit study of the neonatal detection of phenylketonuria and hypothyroidism].
    Dhondt JL; Farriaux JP; Lebrun T; Sailly JC
    Pediatrie; 1988; 43(4):345-8. PubMed ID: 3138627
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Economic evaluation of cost-benefit ratio of neonatal screening procedure for phenylketonuria and hypothyroidism.
    Dhondt JL; Farriaux JP; Sailly JC; Lebrun T
    J Inherit Metab Dis; 1991; 14(4):633-9. PubMed ID: 1749228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A cost-benefit evaluation of neonatal screening for phenylketonuria and congenital hypothyroidism].
    Gu X; Wang J; Ye J; Cheng X
    Zhonghua Yu Fang Yi Xue Za Zhi; 2000 May; 34(3):147-9. PubMed ID: 11860921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Evaluation of the detection of phenylketonuria and hypothyroidism at the Lille Regional Center].
    Dhondt JL; Farriaux JP; Raux M; Paux E; Bouchery AM; Debersée J
    Arch Fr Pediatr; 1987 Nov; 44(9):787-90. PubMed ID: 3446070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Screening of newborn infants in Norway for severe metabolic disease].
    Pettersen RD; Saugstad OD; Heyerdahl S; Motzfeldt K; Lie SO
    Tidsskr Nor Laegeforen; 1995 Feb; 115(5):584-7. PubMed ID: 7900109
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Neonatal screening for congenital hypothyroidism and phenylketonuria].
    Velázquez A; Loera-Luna A; Aguirre BE; Gamboa S; Vargas H; Robles C
    Salud Publica Mex; 1994; 36(3):249-56. PubMed ID: 7940004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Economic evaluation of neonatal screening for phenylketonuria and congenital hypothyroidism.
    Geelhoed EA; Lewis B; Hounsome D; O'leary P
    J Paediatr Child Health; 2005 Nov; 41(11):575-9. PubMed ID: 16398841
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Neonatal screening for metabolic diseases--a task without priority in the Norwegian health policy?].
    Pettersen RD; Saugstad OD; Lie SO
    Tidsskr Nor Laegeforen; 1995 Feb; 115(5):607-8. PubMed ID: 7900116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Screening for phenylketonuria and congenital hypothyroidism in 5.8 million neonates in China].
    Gu XF; Wang ZG
    Zhonghua Yu Fang Yi Xue Za Zhi; 2004 Mar; 38(2):99-102. PubMed ID: 15061917
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [National screening for phenylketonuria, congenital hypothyroidism and congenital adrenal hyperplasia].
    Osório RV; Vilarinho L; Soares JP
    Acta Med Port; 1992 Mar; 5(3):131-4. PubMed ID: 1595380
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Newborn screening for PKU and congenital hypothyroidism in Latvia.
    Lugovska R; Vevere P; Andrusaite R; Kornejeva A
    Southeast Asian J Trop Med Public Health; 1999; 30 Suppl 2():52-3. PubMed ID: 11400783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost effectiveness of establishing a neonatal screening programme for phenylketonuria in Libya.
    Sladkevicius E; Pollitt RJ; Mgadmi A; Guest JF
    Appl Health Econ Health Policy; 2010; 8(6):407-20. PubMed ID: 21043542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pitfalls of newborn screening (with special attention to hypothyroidism): when will we ever learn?
    Holtzman NA
    Birth Defects Orig Artic Ser; 1983; 19(5):111-20. PubMed ID: 6411141
    [No Abstract]   [Full Text] [Related]  

  • 14. [Neonatal screening in Denmark. Status and future perspectives].
    Simonsen H; Brandt NJ; Nørgaard-Pedersen B
    Ugeskr Laeger; 1998 Sep; 160(40):5777-82. PubMed ID: 9782755
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Neonatal screening for phenylketonuria and hypothyroidism in France. A 12-year experience].
    Briard ML
    Ann Biol Clin (Paris); 1988; 46(6):387-92. PubMed ID: 3177978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Examination of newborn infants in the first week. Techniques and objectives including early and systematic screening of congenital hypothyroidism and phenylketonuria].
    Lequien P
    Rev Prat; 1991 Feb; 41(4):357-60. PubMed ID: 2008589
    [No Abstract]   [Full Text] [Related]  

  • 17. Neonatal screening for congenital hypothyroidism and phenylketonuria at Siriraj Hospital, Mahidol University, Bangkok, Thailand--a pilot study.
    Wasant P; Liammongkolkul S; Srisawat C
    Southeast Asian J Trop Med Public Health; 1999; 30 Suppl 2():33-7. PubMed ID: 11400774
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple positive results during a neonatal screening program: a retrospective analysis of incidence, clinical implications and outcomes.
    Zaffanello M; Maffeis C; Zamboni G
    J Perinat Med; 2005; 33(3):246-51. PubMed ID: 15914349
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Programs of systematic screening in neonatology. Pharmaco-economic aspects].
    Schoos R; Verloes A; Bourguignon JP; Koulischer L
    Rev Med Liege; 1998 May; 53(5):311-5. PubMed ID: 9689890
    [TBL] [Abstract][Full Text] [Related]  

  • 20. American Academy of Pediatrics Committee on Genetics: New issues in newborn screening for phenylketonuria and congenital hypothyroidism.
    Pediatrics; 1982 Jan; 69(1):104-6. PubMed ID: 7054742
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.